David Bailey
Stock Analyst at Morgan Stanley
(3.97)
# 1,804
Out of 4,978 analysts
227
Total ratings
50.4%
Success rate
8.9%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $23.90 | $17.49 | +36.69% | 18 | Sep 15, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.70 | $2.33 | +58.80% | 7 | Sep 8, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | n/a | $32.13 | - | 31 | Sep 7, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Sell | $40.90 → $41.90 | $54.98 | -23.79% | 38 | Sep 3, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $172.00 → $182.00 | $176.88 | +2.90% | 33 | Sep 2, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $123.00 → $133.00 | $135.89 | -2.13% | 17 | Sep 1, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Sell | $20.60 → $20.30 | $19.63 | +3.41% | 21 | Sep 1, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $32.70 → $37.90 | $41.96 | -9.68% | 17 | Aug 31, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | n/a | $44.39 | - | 11 | Aug 24, 2026 | |
| RMD ResMed | Reiterated: Hold | $230 | $228.25 | +0.77% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $127.50 → $152.50 | $168.48 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.50 → $1.35 | $0.44 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.05 → $3.55 | $4.78 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.75 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.36 | $3.03 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $0.95 | n/a | 1 | Jan 21, 2021 |
Telix Pharmaceuticals Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $23.90
Current: $17.49
Upside: +36.69%
Integral Diagnostics Limited
Sep 8, 2026
Reiterated: Buy
Price Target: $3.70
Current: $2.33
Upside: +58.80%
ResMed Inc.
Sep 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $32.13
Upside: -
Ramsay Health Care Limited
Sep 3, 2026
Reiterated: Sell
Price Target: $40.90 → $41.90
Current: $54.98
Upside: -23.79%
CSL Limited
Sep 2, 2026
Reiterated: Buy
Price Target: $172.00 → $182.00
Current: $176.88
Upside: +2.90%
Cochlear Limited
Sep 1, 2026
Reiterated: Hold
Price Target: $123.00 → $133.00
Current: $135.89
Upside: -2.13%
Sonic Healthcare Limited
Sep 1, 2026
Reiterated: Sell
Price Target: $20.60 → $20.30
Current: $19.63
Upside: +3.41%
Ansell Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $32.70 → $37.90
Current: $41.96
Upside: -9.68%
Fisher & Paykel Healthcare Corporation Limited
Aug 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $44.39
Upside: -
ResMed
Jul 13, 2026
Reiterated: Hold
Price Target: $230
Current: $228.25
Upside: +0.77%
Aug 15, 2024
Reiterated: Buy
Price Target: $127.50 → $152.50
Current: $168.48
Upside: n/a
Feb 28, 2024
Reiterated: Hold
Price Target: $1.50 → $1.35
Current: $0.44
Upside: n/a
Jan 31, 2024
Reiterated: Buy
Price Target: $3.05 → $3.55
Current: $4.78
Upside: n/a
Aug 24, 2021
Reiterated: Hold
Price Target: n/a
Current: $13.75
Upside: n/a
Jan 21, 2021
Reiterated: Hold
Price Target: $0.36
Current: $3.03
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $0.95
Upside: n/a